Skip to main content
Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.680
-0.110 (-6.15%)
At close: Nov 13, 2026, 4:00 PM EST
1.810
+0.130 (7.74%)
After-hours: Nov 13, 2026, 5:37 PM EST

Ernexa Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
2.74M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024582.00K514.00K755.88%
Dec 31, 202368.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 201224.06M194.00K0.81%
Dec 31, 201123.87M-1.44M-5.69%
Dec 31, 201025.31M-505.00K-1.96%
Dec 31, 200925.81M-1.68M-6.12%
Dec 31, 200827.50M-3.05M-9.97%
Dec 31, 200730.54M-2.44M-7.41%
Dec 31, 200632.99M2.24M7.27%
Dec 31, 200530.75M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Traws Pharma2.73M
VivoSim Labs112.00K
Jupiter Neurosciences64.69K
Silo Pharma54.08K
Azitra7.50K
Revenue Rankings

ERNA News

More News